-transparent.png){kind=logo}
The purpose of the present study was to determine after what time period hydroxyl radical formation contributes most to ischemic brain damage in focal ischemia, using a hydroxyl radical scavenger, EPC-K1, L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-tridecyl)-2H-1-be nzopyran-6yl-hydrogen phosphate] potassium salt. Focal ischemia was produced by thrombotic occlusion of the left middle cerebral artery in rats. After evaluation of the pharmacokinetics of EPC-K in the brain tissue and plasma following 10 mg/kg intravenous bolus treatment of conscious rats, we investigated the neuroprotective effect of EPC-K1 in the middle cerebral artery occlusion model. A single intravenous bolus of EPC-K1 was given immediately, 3 or 6 h after ischemia, and cerebral brain damage was measured 24 h after ischemia. When EPC-K1 was injected 3 h after ischemia, a significant (P < 0.01) reduction of cerebral brain damage was observed. EPC-K1 delivered by intravenous infusion that started immediately after ischemia and lasted for 24 h, also significantly (P < 0.05) reduced brain damage, but the efficacy of the neuroprotective effect was the same as that of the 3 h after ischemia bolus treatment. These results may indicate that the period of hydroxyl radical formation most critical for ischemic brain damage is a few hours after the third hour following ischemia in this model.
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
September 1993,
Experimental eye research,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
January 1985,
Progress in brain research,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
January 2009,
Neurotoxicity research,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
June 1996,
No to shinkei = Brain and nerve,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
May 2003,
Journal of neurotrauma,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
January 1992,
Journal of nutritional science and vitaminology,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
January 1995,
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
February 1993,
Journal of neurochemistry,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
March 2016,
European journal of pharmacology,
H Takamatsu, and
K Kondo, and
Y Ikeda, and
K Umemura
December 2008,
Journal of the American Society of Nephrology : JASN,
